• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种源自胰腺的新型人腺泡细胞癌细胞系Faraz-ICR的建立与鉴定

Establishment and characterization of a new human acinar cell carcinoma cell line, Faraz-ICR, from pancreas.

作者信息

Rezaei Marzieh, Hosseini Ahmad, Nikeghbalian Saman, Ghaderi Abbas

机构信息

Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran; Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

出版信息

Pancreatology. 2017 Mar-Apr;17(2):303-309. doi: 10.1016/j.pan.2017.02.003. Epub 2017 Feb 8.

DOI:10.1016/j.pan.2017.02.003
PMID:28215484
Abstract

OBJECTIVES

Basic research in the field of acinar cell carcinoma (ACC) as a rare neoplasm of the pancreas is dependent on the availability of pragmatic model such as new pancreatic cancer cell lines. Thus, establishment and characterization of new pancreatic cancer cell lines from ACC origin are deemed important.

METHODS

Faraz-ICR cell line was derived from a 58-years old woman with pancreatic acinar cell carcinoma by the collagenase digestion protocol. We characterized the cell line by examining its morphology and cytostructural and functional profile.

RESULTS

Faraz-ICR has a doubling time of 35 hours and grows in soft agar with a colony-forming efficiency of 25%. The cell had nearly normal pattern of chromosomes in karyotype analysis and Comparative Genomic Hybridization (CGH) array analysis. Evaluation of cells by flowcytometry showed that Faraz-ICR is negative for EpCAM and mesenchymal markers in different passages, and has epithelial nature. Immunofluorescence staining revealed that cells were strongly positive for vimentin, desmin, ezrin, S100, nestin and they were negative for pan-cytokeratins, chromogranin and alpha smooth muscle actin.

CONCLUSIONS

We were able to establish a new pancreatic carcinoma cell line with partial aspects of Epithelial-mesenchymal transition and aggressiveness. This cell line might be suitable for studying various anticancer drugs and protein profile aiming to see any possible tumor associated marker for ACC.

摘要

目的

胰腺腺泡细胞癌(ACC)作为一种罕见的胰腺肿瘤,其基础研究依赖于实用模型的可用性,如新的胰腺癌细胞系。因此,建立并鉴定源自ACC的新胰腺癌细胞系被认为很重要。

方法

通过胶原酶消化法从一名58岁患有胰腺腺泡细胞癌的女性患者中获得了Faraz-ICR细胞系。我们通过检查其形态、细胞结构和功能特征来鉴定该细胞系。

结果

Faraz-ICR的倍增时间为35小时,能在软琼脂中生长,集落形成效率为25%。在核型分析和比较基因组杂交(CGH)阵列分析中,该细胞的染色体模式近乎正常。通过流式细胞术对细胞进行评估显示,Faraz-ICR在不同传代中上皮细胞黏附分子(EpCAM)和间充质标志物呈阴性,具有上皮性质。免疫荧光染色显示,细胞波形蛋白、结蛋白、埃兹蛋白、S100、巢蛋白呈强阳性,而泛细胞角蛋白、嗜铬粒蛋白和α平滑肌肌动蛋白呈阴性。

结论

我们成功建立了一种具有部分上皮-间质转化和侵袭性特征的新胰腺癌细胞系。该细胞系可能适合用于研究各种抗癌药物和蛋白质谱,以寻找ACC可能的肿瘤相关标志物。

相似文献

1
Establishment and characterization of a new human acinar cell carcinoma cell line, Faraz-ICR, from pancreas.一种源自胰腺的新型人腺泡细胞癌细胞系Faraz-ICR的建立与鉴定
Pancreatology. 2017 Mar-Apr;17(2):303-309. doi: 10.1016/j.pan.2017.02.003. Epub 2017 Feb 8.
2
4H12, a Murine Monoclonal Antibody Directed against Myosin Heavy Chain-9 Expressed on Acinar Cell Carcinoma of Pancreas with Potential Therapeutic Application.4H12,一种针对胰腺腺泡细胞癌中表达的肌球蛋白重链9的鼠单克隆抗体,具有潜在治疗应用价值。
Iran Biomed J. 2021 Sep 1;25(5):310-22. doi: 10.52547/ibj.25.5.310.
3
Production of a Mouse Monoclonal Antibody Against Mortalin by Whole Cell Immunization.通过全细胞免疫制备抗mortalin的小鼠单克隆抗体
Monoclon Antib Immunodiagn Immunother. 2017 Aug;36(4):169-175. doi: 10.1089/mab.2017.0013. Epub 2017 Jul 18.
4
Monoclonal Antibody Production Against Vimentin by Whole Cell Immunization in a Mouse Model.在小鼠模型中通过全细胞免疫产生抗波形蛋白单克隆抗体
Iran J Biotechnol. 2018 May 15;16(2):e1802. doi: 10.21859/ijb.1802. eCollection 2018 May.
5
Establishment and characterization of 4 new human pancreatic cancer cell lines: evidences of different tumor phenotypes.4种新的人胰腺癌细胞系的建立与鉴定:不同肿瘤表型的证据
Pancreas. 2009 Mar;38(2):184-96. doi: 10.1097/MPA.0b013e31818c746a.
6
Establishment and Characterization of a New Triple Negative Breast Cancer Cell Line from an Iranian Breast Cancer Tissue.源自伊朗乳腺癌组织的新型三阴性乳腺癌细胞系的建立与鉴定
Asian Pac J Cancer Prev. 2019 Jun 1;20(6):1683-1689. doi: 10.31557/APJCP.2019.20.6.1683.
7
EZB-ICR Cell Line: A New Established and Characterized Oral Squamous Cell Carcinoma Cell Line From Tongue.EZB-ICR 细胞系:一种源自舌部的新建立和特征明确的口腔鳞状细胞癌细胞系。
Asian Pac J Cancer Prev. 2021 Jan 1;22(1):99-103. doi: 10.31557/APJCP.2021.22.1.99.
8
Pancreatic-type Acinar Cell Carcinoma of the Stomach Included in Multiple Primary Carcinomas.包含在多原发性癌中的胃胰腺型腺泡细胞癌
Anticancer Res. 2016 Jun;36(6):2855-64.
9
Five primary human pancreatic adenocarcinoma cell lines established by the outgrowth method.五种通过体外培养方法建立的人胰腺导管腺癌细胞系。
J Surg Res. 2012 Jan;172(1):29-39. doi: 10.1016/j.jss.2011.04.021. Epub 2011 May 7.
10
Pancreas-specific activation of mTOR and loss of p53 induce tumors reminiscent of acinar cell carcinoma.胰腺特异性的mTOR激活和p53缺失会诱发类似于腺泡细胞癌的肿瘤。
Mol Cancer. 2015 Dec 18;14:212. doi: 10.1186/s12943-015-0483-1.

引用本文的文献

1
Derivation of pancreatic acinar cell carcinoma cell line HS-1 as a patient-derived tumor organoid.胰腺腺泡细胞癌细胞系 HS-1 的衍生作为患者来源的肿瘤类器官。
Cancer Sci. 2023 Mar;114(3):1165-1179. doi: 10.1111/cas.15656. Epub 2022 Nov 27.
2
4H12, a Murine Monoclonal Antibody Directed against Myosin Heavy Chain-9 Expressed on Acinar Cell Carcinoma of Pancreas with Potential Therapeutic Application.4H12,一种针对胰腺腺泡细胞癌中表达的肌球蛋白重链9的鼠单克隆抗体,具有潜在治疗应用价值。
Iran Biomed J. 2021 Sep 1;25(5):310-22. doi: 10.52547/ibj.25.5.310.
3
Establishment and characterization of a new human colon cancer cell line, PUMC-CRC1.
建立并鉴定人结肠癌新细胞系 PUMC-CRC1。
Sci Rep. 2021 Jun 23;11(1):13122. doi: 10.1038/s41598-021-92491-7.
4
Monoclonal Antibody Production Against Vimentin by Whole Cell Immunization in a Mouse Model.在小鼠模型中通过全细胞免疫产生抗波形蛋白单克隆抗体
Iran J Biotechnol. 2018 May 15;16(2):e1802. doi: 10.21859/ijb.1802. eCollection 2018 May.